Identifying immune infiltration pattern of PD-L1 positive and negative lung adenocarcinoma

被引：0
|
作者：
Heidel, C. [1 ,2 ]
Jokic, M. [1 ,2 ]
Faehnrich, A. [3 ]
Kuempers, C. [1 ,2 ]
Vogel, W. [1 ,2 ]
Vlasic, I. [1 ,2 ]
Kirfel, J. [1 ,2 ]
Busch, H. [3 ]
Perner, S. [1 ,2 ]
机构：
[1] Univ Hosp Schleswig Holstein, Inst Pathol, Campus Luebeck, Lubeck, Germany
[2] Leibniz Lung Ctr, Res Ctr Borstel, Pathol, Borstel, Germany
[3] Univ Lubeck, Inst Expt Dermatol, Lubeck, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P407
引用
下载
收藏
页码：110 / 111
页数：2
相关论文
共 50 条
  • [1] BIRC5 Modulates PD-L1 Expression and Immune Infiltration in Lung Adenocarcinoma
    Ma, Teng
    Gu, Jie
    Wen, Haoyu
    Xu, Fengkai
    Ge, Di
    JOURNAL OF CANCER, 2022, 13 (10): : 3140 - 3150
  • [2] Infiltration of TAMs is involved in tumor PD-L1 expression in early lung adenocarcinoma
    Shima, Toshiyuki
    Shimoda, Masayuki
    Shigenobu, Takao
    Otsuka, Takashi
    Nishimura, Tomoyasu
    Emoto, Katsura
    Hayashi, Yuichirou
    Iwasaki, Tatusrou
    Abe, Takayuki
    Asamura, Hisao
    Kanai, Yae
    CANCER SCIENCE, 2021, 112 : 397 - 397
  • [3] CD44 Confers Worsened Prognosis in Lung Adenocarcinoma and is Positively Correlated With PD-L1 and Immune Cells Infiltration
    Zhang, C.
    Wang, H.
    Wang, X.
    Yu, H.
    Zhao, C.
    Wang, H.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S556 - S556
  • [4] A comparative study of PD-L1 diagnostic assays and the classification of patients as PD-L1 positive and PD-L1 negative
    Ratcliffe, Marianne J.
    Sharpe, Alan
    Midha, Anita
    Barker, Craig
    Scorer, Paul
    Walker, Jill
    CANCER RESEARCH, 2016, 76
  • [5] Cyclic adenosine monophosphate/phosphodiesterase 4 pathway associated with immune infiltration and PD-L1 expression in lung adenocarcinoma cells
    Tong, Ling
    Shan, Minjie
    Zou, Wen
    Liu, XianLing
    Felsher, Dean W.
    Wang, Jingjing
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] PD-L1 EXPRESSION IN SUBTYPES OF ADENOCARCINOMA OF THE LUNG
    Son, Choonhee
    CHEST, 2019, 156 (04) : 307A - 307A
  • [7] Lung Adenocarcinoma Expression of the Aryl Hydrocarbon Receptor Promotes PD-L1 and Immune Suppression
    Snyder, Megan
    Lara, Brian
    Wang, Zhongyan
    Fimbres, Jocelyn
    Khan, Mohammed Muzamil
    Song, Gang
    Mazzilli, Sarah A.
    Monti, Stefano
    Sherr, David
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [8] Clinicopathological Characteristics of PD-L1 Expression in Lung Adenocarcinoma
    Wu, Shafei
    Shi, Xiaohua
    Sun, Jian
    Liu, Yuanyuan
    Liang, Zhiyong
    Zeng, Xuan
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S816 - S816
  • [9] What does PD-L1 positive or negative mean?
    Ribas, Antoni
    Hu-Lieskovan, Siwen
    JOURNAL OF EXPERIMENTAL MEDICINE, 2016, 213 (13): : 2835 - 2840
  • [10] Immune cell screen of tumor micro environment of PD-L1 in positive/negative bladder cancer, melanoma, and lung cancer
    Gonzalez, Rachel
    Fu, Wei
    Logis, Evelin
    Chen, Casey
    Cone, Tiffany
    Merritt, Sonia
    Wang, Yiran
    Wang, Guanli
    Ma, Donghui
    CANCER RESEARCH, 2019, 79 (13)
12345